Xeris Biopharma Reports Strong Financial Results for Fiscal Year 2024
Xeris Biopharma announced a total revenue of $163.9 million for the fiscal year ending on March 6, 2024. The company ...
Tag: XERS
Xeris Biopharma Holdings Reports Strong Fourth Quarter Financial Results
Xeris Biopharma Holdings (NASDAQ:XERS) announced their fourth-quarter financial results on March 6, 2024. The company reported a GAAP EPS of ...
Title Xeris Biopharma Holdings Inc Completes Financial Restructuring with Hayfin Capital Management LLP
Xeris Biopharma Holdings, Inc. has recently completed a significant financial restructuring on March 6, 2024. The company successfully refinanced its ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Strategic Shift: Kazatomprom Curtails Production and Denies Listing Rumors
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
